Brief: Cantargia Receives Regulatory Approval For Phase I Trial For CAN10

Cantargia AB

10/08/2023 14:37

Aug 10 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA RECEIVES REGULATORY APPROVAL TO START PHASE I
CLINICAL
TRIAL FOR CAN10
    * UP TO 80 SUBJECTS MAY BE INCLUDED IN TRIAL, WHICH IS
EXPECTED TO
START IN SEPTEMBER 2023

Source text for Eikon:  ID:nMFN7vPdkC 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))